Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 49
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Pα+ Psychedelic Bulletin #188: Q4’24 Lobbying Update; Virginia Lawmakers Question Purpose,...
Psychedelic Funding, Public Markets, and M&A in 2024
Neeka Levy and Zach Skiles – Healing Ukraine Trauma
Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes...
Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game;...
How Psychedelics Impact the Mind: Mysticism, Mental Health, and the Future...
GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant...
2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis
The Psychedelic News Feed: September 2, 2024 – December 29, 2024
Psychedelic Drug Development Pipeline Updates (Q1’25)
Load more
